GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,452 | -50.0% | 6,754 | -33.8% | 0.00% | – |
| Q2 2023 | $38,896 | +362.2% | 10,209 | +125.7% | 0.00% | – |
| Q1 2023 | $8,415 | +0.8% | 4,524 | +24.6% | 0.00% | – |
| Q4 2022 | $8,349 | -44.3% | 3,630 | -21.6% | 0.00% | – |
| Q3 2022 | $15,000 | -46.4% | 4,630 | -9.9% | 0.00% | – |
| Q2 2022 | $28,000 | +27.3% | 5,140 | -46.1% | 0.00% | – |
| Q1 2022 | $22,000 | -38.9% | 9,540 | +61.4% | 0.00% | – |
| Q4 2021 | $36,000 | -80.7% | 5,910 | -56.1% | 0.00% | – |
| Q3 2021 | $187,000 | – | 13,464 | +134540.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 10 | -99.9% | 0.00% | – |
| Q1 2021 | $119,000 | – | 7,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,153,206 | $5,864,963 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,360,580 | $4,390,679 | 0.73% |
| Orbimed Advisors | 9,497,774 | $17,665,860 | 0.35% |
| Vivo Capital, LLC | 1,463,983 | $2,723,008 | 0.19% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $18,417,608 | 0.11% |
| EcoR1 Capital, LLC | 798,948 | $1,486,043 | 0.05% |
| Brainard Capital Management LLC | 25,913 | $48,198 | 0.04% |
| Schonfeld Strategic Advisors LLC | 613,179 | $1,140,512 | 0.01% |
| FEDERATED HERMES, INC. | 1,298,578 | $2,415,355 | 0.01% |
| Cannell Capital | 14,299 | $26,596 | 0.01% |